Haemonetics Corporation (HAE) Financial Statements (2024 and earlier)

Company Profile

Business Address 125 SUMMER STREET
BOSTON, MA 02110
State of Incorp. MA
Fiscal Year End March 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
MRQ
3/31/2023
12/31/2022
MRQ
3/31/2022
3/31/2021
3/31/2020
3/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments284,466224,002259,496192,305137,311169,351
Cash and cash equivalents284,466224,002259,496192,305137,311169,351
Receivables179,142181,100159,376127,555165,207185,027
Inventory, net of allowances, customer advances and progress billings259,379255,756293,027322,614270,276194,337
Inventory259,379255,756293,027322,614270,276194,337
Other undisclosed current assets46,73545,45144,13251,07230,84527,406
Total current assets:769,722706,309756,031693,546603,639576,121
Noncurrent Assets
Property, plant and equipment310,885313,138258,482217,559253,399343,979
Intangible assets, net (including goodwill)742,002750,495777,548831,927343,758338,512
Goodwill466,231466,112467,287466,444210,652210,819
Intangible assets, net (excluding goodwill)275,771284,383310,261365,483133,106127,693
Deferred income tax assets5,2414,8424,4686,0093,930
Other noncurrent assets106,975103,28263,20570,88262,38411,796
Other undisclosed noncurrent assets      4,359
Total noncurrent assets:1,165,1031,171,7571,103,7031,126,377663,471698,646
TOTAL ASSETS:1,934,8251,878,0661,859,7341,819,9231,267,1101,274,767
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities128,404115,951106,91197,893100,201116,561
Employee-related liabilities64,47552,18248,54047,60049,47153,200
Accounts payable63,92963,76958,37150,29350,73063,361
Accrued liabilities      
Debt11,7849,949214,14817,01676,98027,666
Other liabilities111,628100,989121,207138,58697,64191,532
Total current liabilities:251,816226,889442,266253,495274,822235,759
Noncurrent Liabilities
Long-term debt and lease obligation754,102756,826559,441690,592305,513322,454
Long-term debt, excluding current maturities754,102756,826559,441690,592305,513322,454
Liabilities, other than long-term debt110,910118,372108,603144,16699,66648,686
Deferred tax liabilities, net19,906
Deferred income tax liabilities36,19540,15228,72743,82510,562
Other liabilities74,71578,22079,876100,34189,10428,780
Total noncurrent liabilities:865,012875,198668,044834,758405,179371,140
Total liabilities:1,116,8281,102,0871,110,3101,088,253680,001606,899
Equity
Equity, attributable to parent817,997775,979749,424731,670587,109667,868
Common stock504504511509503510
Additional paid in capital594,706587,489572,476602,727553,229536,320
Accumulated other comprehensive loss(30,381)(35,799)(25,954)(29,547)(45,135)(30,380)
Retained earnings253,168223,785202,391157,98178,512161,418
Total equity:817,997775,979749,424731,670587,109667,868
TOTAL LIABILITIES AND EQUITY:1,934,8251,878,0661,859,7341,819,9231,267,1101,274,767

Income Statement (P&L) ($ in thousands)

12/31/2023
TTM
3/31/2023
12/31/2022
TTM
3/31/2022
3/31/2021
3/31/2020
3/31/2019
Revenues1,168,6601,212,006993,196870,463988,479967,579
Cost of revenue
(Cost of Goods and Services Sold)
(553,563)(563,687)(487,694)(472,625)(503,966)(550,043)
Gross profit:615,097648,319505,502397,838484,513417,536
Operating expenses(459,064)(557,713)(424,752)(308,091)(381,162)(333,991)
Operating income:156,03390,60680,75089,747103,35183,545
Nonoperating expense
(Other Nonoperating expense)
(14,630)(18,510)(17,121)(16,834)(16,199)(9,912)
Interest and debt expense (13,000) (5,800)(9,400)(13,500) 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes (5,800) 9,40013,500 
Income from continuing operations before equity method investments, income taxes:128,40366,29657,82972,91387,15273,633
Other undisclosed income from continuing operations before income taxes13,0005,8005,800   
Income from continuing operations before income taxes:141,40372,09663,62972,91387,15273,633
Income tax expense (benefit)(26,002)(33,213)(20,254)6,556(10,626)(18,614)
Income from continuing operations:115,40138,88343,37579,46976,52655,019
Income before gain (loss) on sale of properties:5,93943,37579,46976,52655,019
Net income available to common stockholders, diluted:115,40138,88343,37579,46976,52655,019

Comprehensive Income ($ in thousands)

12/31/2023
TTM
3/31/2023
12/31/2022
TTM
3/31/2022
3/31/2021
3/31/2020
3/31/2019
Net income:115,40138,88343,37579,46976,52655,019
Other comprehensive income (loss)(4,427)(21,529)3,59315,588(14,755)(11,389)
Comprehensive income, net of tax, attributable to parent:110,97417,35446,96895,05761,77143,630

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: